December 2nd 2024
If granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Lesion size, location dictate decision on pediatric surgery
April 1st 2002New Orleans - Timing is key for a successful outcome when performing dermatologic surgery in pediatric patients, and lesion size and location are the two most important variables factoring into the equation, Annette M. Wagner, M.D., said at the annual meeting of the American Academy of Dermatology.
Systemic CD often an elusive diagnosis
April 1st 2002New Orleans - Systemic contact dermatitis may present with a variety of eczematous and noneczematous cutaneous reaction patterns and may be an overlooked diagnosis unless clinicians maintain an index of suspicion that systemic exposure to a contact allergen is driving the skin eruption, Donald V. Belsito, M.D., said at the annual meeting of the American Academy of Dermatology.
Infliximab finds utility in management of pyoderma gangrenosum
April 1st 2002New Orleans - The experiences of an expanding series of patients indicate infliximab (Remicade) is a valuable therapy for the management of pyoderma gangrenosum (PG), Marketa Limova, M.D., said at the annual meeting of the American Academy of Dermatology.
Achilles, great toe play diabetic role
April 1st 2002Los Angeles -- Diabetic ulcers can be reduced or even eliminated by correcting abnormal biomechanics of the feet, including a tight Achilles tendon and limited motion of the great toe, researchers said at the annual meeting of the American College of Foot and Ankle Surgeons
Simple tricks stem pediatric surgery pitfalls
March 2nd 2002Keeping a little 'up the sleeve' when applying local anesthesia maximizesefficacy and episode outcomesNew Orleans - Attention to scheduling and techniques for localanesthesia delivery and suturing are important in making dermatologic surgerya favorable experience for children and achieving an optimal cosmetic result,said Annette M. Wagner, M.D., at the annual meeting of the American Academyof Dermatology.
She is not 18; can she provide informed consent?
March 2nd 2002Jane, a very mature 17-year-old adolescent, presents to Dr. Jones forremoval of a facial nevus. Dr. Jones discusses the risk/benefit ratio ofsuch an excision. In the course of the discussion, he determines that sheis working a full-time job and lives with her boyfriend at home with herparents. She signs a standard consent form. Dr. Jones does not realize thatshe is 17; he did not ask. Ultimately she is not happy with the scar andwishes to sue her dermatologist. The basis of her suit is that at age 17she was not able to provide informed consent. Dr. Jones is aware that, asa general rule, a patient must be 18 years of age to provide informed consent.However, he contends that Jane was highly intelligent, articulate and hada better understanding of the procedure than some 19 year olds might have.Can Jane, as an adolescent, give informed consent?
Infliximab dramatically clears severe psoriasis
March 1st 2002New Orleans - The experience of a teenage girl treated successfully with infliximab (Remicade) for severe, recalcitrant psoriasis of her hands and feet indicates the value of the TNF-alpha chimeric monoclonal antibody as a therapeutic option for psoriasis.
Topical tacrolimus improves vitiligo; adding sunlight may help even more
March 1st 2002New Orleans - Results from an exploratory study indicate a potential role for topical tacrolimus in the management of vitiligo, Emil A. Tanghetti, M.D., said at the annual meeting of the American Academy of Dermatology.